SynthesisFrontiers in nutrition2026
The effect of DASH diet on components of metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.
Synthesis in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metabolic syndrome (MetS) has emerged as an increasingly significant global health issue. The Dietary Approaches to Stop Hypertension (DASH) diet is recommended for managing MetS. However, existing meta-analyses often focus on individual MetS components, without providing a comprehensive evaluation of the DASH diet's effects on the full spectrum of MetS components. Therefore, we conducted a systematic review and meta-analysis of randomized controlled trials evaluating the effects of the DASH diet on various components of MetS. Methods: We performed a comprehensive search of PubMed, Web of Science, Embase, and Cochrane Library databases, covering studies published until April 6, 2025. We included RCTs that evaluated the effects of the DASH diet on MetS components such as waist circumference (WC), blood pressure (BP), fasting blood glucose (FBG), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), and Homeostasis Model Assessment-Insulin Resistance (HOMA-IR). Sensitivity analyses were conducted to assess result stability, and funnel plots were used to assess publication bias, with Egger's test applied for significance ( Results: A total of 14 studies involving 1,062 participants were included. The meta-analysis showed that, compared with non-DASH diets, the DASH diet significantly reduced WC (MD = -2.33 cm, 95% CI: -3.10 to -1.57), systolic BP (MD = -5.52 mmHg, 95% CI: -6.83 to -4.21), diastolic BP (MD = -3.93 mmHg, 95% CI: -4.76 to -3.10), TG (MD = -16.57 mg/dL, 95% CI: -23.53 to -9.61), HDL-C (MD = 1.44 mg/dL, 95% CI: 0.20 to 2.68), and HOMA-IR levels (MD = -0.71, 95% CI: -1.10 to -0.31). However, no significant difference was observed in FBG (MD = -0.91 mg/dL, 95% CI: -4.51 to 2.68). The GRADE approach for assessing certainty of evidence indicated that, with the exception of FBG and HDL-C where the certainty of evidence was low, the overall certainty of evidence for the remaining outcome measures was rated as moderate quality. Conclusion: The DASH diet appears to have a positive effect on components of MetS and can be considered an effective dietary intervention for MetS patients. Systematic review registration: CRD420251060235.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.